Lario Therapeutics

Neuron
#Funding #Lario Therapeutics #Neuroscience #Parkinson's #The Michael J Fox Foundation for Parkinson’s Research (MJFF)

$2.4m funds neuronal calcium channel platform for Parkinson’s

Lario Therapeutics has received a total of $2.4 million in grant funding from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Wellcome to support the continued expansion of its neuronal calcium channel drug discovery platform.  With the proceeds of these awards, Lario is expanding its… Read More

#Business & Investment #News

Human brain
#Funding #Lario Therapeutics #Parkinson's #The Michael J Fox Foundation for Parkinson’s Research (MJFF)

Lario Therapeutics awarded $6m for Parkinson’s drug research

Biopharmaceutical company Lario Therapeutics has been awarded a $6 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The grant will be used to fund Lario’s preclinical programme investigating selective CaV2.3 calcium channel inhibition as a novel and disease-modifying approach for treatment of… Read More

#News